UniSuper Management Pty Ltd Purchases 23,581 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

UniSuper Management Pty Ltd increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 14.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 184,745 shares of the pharmacy operator's stock after acquiring an additional 23,581 shares during the quarter. UniSuper Management Pty Ltd's holdings in Walgreens Boots Alliance were worth $1,724,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. First Financial Corp IN boosted its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $26,000. Riverview Trust Co boosted its stake in Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after buying an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the 4th quarter valued at approximately $28,000. Finally, TD Private Client Wealth LLC increased its stake in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after acquiring an additional 3,208 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Evercore ISI lifted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research report on Monday, January 13th. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their target price for the company from $11.00 to $9.00 in a research note on Friday, February 28th. Finally, StockNews.com assumed coverage on Walgreens Boots Alliance in a report on Thursday. They set a "hold" rating for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance has an average rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Stock Down 3.4 %

NASDAQ:WBA traded down $0.38 during mid-day trading on Friday, reaching $10.68. The company's stock had a trading volume of 26,004,429 shares, compared to its average volume of 20,848,132. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $19.48. The stock has a fifty day moving average of $10.75 and a 200-day moving average of $9.97. The firm has a market capitalization of $9.23 billion, a PE ratio of -1.04, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analysts' expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company's revenue was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.66 EPS. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.